Refine by MP, party, committee, province, or result type.

Results 1-15 of 300
Sorted by relevance | Sort by date: newest first / oldest first

Health committee  Thank you, Madam Chair, for the questions. In terms of cost savings, we have made significant investments in e-health, and we have seen that it can reduce travel in two ways. First, and perhaps most importantly, for patients, if we can connect them to health providers through te

April 18th, 2013Committee meeting

Glenda Yeates

Health committee  Thank you again for question. Madam Chair, I certainly would agree that the Patented Medicine Prices Review Board is a very critical and important institution. I would characterize the reduction in two ways. One is that there are some administrative savings that they have found

April 18th, 2013Committee meeting

Glenda Yeates

Health committee  If I might continue, Madam Chair, I should be clear here about the role. Health Canada is very concerned about the strict screening and the safety, because we are the regulator. We are very concerned about the safety of these products. That is our role, to make sure nothing in an

April 18th, 2013Committee meeting

Glenda Yeates

Health committee  I'll start with the answer, Madam Chair, and it may be that my colleague from CIHR will continue. There is an announcement in budget 2013—I'm just looking for my notes on this—of a renewal of funding for Genome Canada. That is an organization outside the Health portfolio but ob

April 18th, 2013Committee meeting

Glenda Yeates

Health committee  I think there has been really heightened awareness of the importance of these substances in our health system as a result of recent years. Budget 2013 does provide $141 million over two years to secure a supply of medical isotopes, and maintain safe and reliable operations at Ato

April 18th, 2013Committee meeting

Glenda Yeates

Health committee  Thank you, Madam Chair. Working with the provinces and territories is among our objectives. However, the issues we deal with can change. For instance, a few years ago, we focused on the waiting list issue. We talked about health human resources. For the time being, the Council

April 18th, 2013Committee meeting

Glenda Yeates

Health committee  Thank you very much for the question. I understand the question to be about the chemotherapy situation currently in Ontario. Is that correct?

April 18th, 2013Committee meeting

Glenda Yeates

Health committee  It's obviously a very important issue. I think we have all been working very closely together with the Province of Ontario, with provincial officials, and with the Ontario College of Pharmacists to address the situation. We understand there's a situation in which compounds that

April 18th, 2013Committee meeting

Glenda Yeates

Health committee  Thank you again for the opportunity to continue the dialogue on this very important question. As I said, there's no change. Blood used for transfusion by both the Canadian Blood Services and Héma-Québec is collected only from volunteer donors. Plasma is also collected from donor

April 18th, 2013Committee meeting

Glenda Yeates

Health committee  Thank you very much for the question, Madam Chair. I'm happy to answer it. Because we're comparing all-year funding with supplementary estimates (A), (B), and (C) in the previous year to the main estimates in this year, the funding looks very significant, as was noted, but I can

April 18th, 2013Committee meeting

Glenda Yeates

Health committee  The combination of those four items I mentioned is the difference in total.

April 18th, 2013Committee meeting

Glenda Yeates

Health committee  I'm sorry, Madam Chair, I missed the title.

April 18th, 2013Committee meeting

Glenda Yeates

Health committee  Thank you.

April 18th, 2013Committee meeting

Glenda Yeates

Health committee  Thank you very much. I'm very pleased, Madam Chair, to respond to this question. As the committee has reflected in the past, or discussed in the past, the courts have been clear that what we need to maintain in the country is reasonable access to marijuana for medical purposes

April 18th, 2013Committee meeting

Glenda Yeates

Health committee  Thank you very much for the question. We are doing the consulting now. We are in the phase of putting out the proposals and getting the feedback. One thing we have done is to put out information to potential licensed producers. We are in dialogue with them, asking them to thin

April 18th, 2013Committee meeting

Glenda Yeates